Keywords
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D; use, select 'Corporate R&D; Professionals'
Subscribe:
Subscribe to The American Journal of Emergency MedicineReferences
- Addressing prescription drug abuse in the United States: Current activities and future opportunities.in: Prescription drug abuse: Reduction efforts and Federal Role. 2015
- Controlled substance, drug, device and cosmetic act-drug overdose response immunity.13. 2014: 139
- Legal changes to increase access to naloxone for opioid overdose reversal in the United States.Drug Alcohol Depend. 2015; 2015 (October): 112-120https://doi.org/10.1016/j.drugalcdep.2015.10.013
- Overview of naloxone access and good Samaritan laws.2017: 18
- Police officers can safely and effectively administer intranasal naloxone.Prehospital Emerg Care. 2016; 20: 675-680https://doi.org/10.1080/10903127.2016.1182605
- Use of naloxone nasal spray 4 mg in the community setting: a survey of use by community organizations.Curr Med Res Opin. 2018; https://doi.org/10.1080/03007995.2017.1334637
- Expanded access to naloxone among firefighters, police officers, and emergency medical technicians in Massachusetts.Am J Public Health. 2014; https://doi.org/10.2105/AJPH.2014.302062
- Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths.Am J Emerg Med. 2015; https://doi.org/10.1016/j.ajem.2015.05.022
- The opioid epidemic and the role of law enforcement officers in saving lives.Vict Offenders. 2018; https://doi.org/10.1080/15564886.2018.1514552
Article Info
Publication History
Footnotes
☆The authors have no outside support information, conflicts or financial interest to disclose. This study, in part, was funded by an unrestricted grant, The Dorothy Rider Pool Trust for Health Research and Education community foundation grant (2018). In addition, this was supported by a Philadelphia College of Osteopathic Medicine MEDNet grant (2018). An abstract was presented at the ACEP 2019 Research Forum. This study was IRB approved by the Lehigh Valley Health Network IRB (IRB # STUDY00000054) on 2/16/2018.